CHAPTER 1: INTRODUCTION
1.1. Report description
1.2. Key market segments
1.3. Key benefits to the stakeholders
1.4. Research Methodology
1.4.1. Primary research
1.4.2. Secondary research
1.4.3. Analyst tools and models
CHAPTER 2: EXECUTIVE SUMMARY
2.1. CXO Perspective
CHAPTER 3: MARKET OVERVIEW
3.1. Market definition and scope
3.2. Key findings
3.2.1. Top impacting factors
3.2.2. Top investment pockets
3.3. Porter’s five forces analysis
3.3.1. Bargaining power of suppliers
3.3.2. Bargaining power of buyers
3.3.3. Threat of substitutes
3.3.4. Threat of new entrants
3.3.5. Intensity of rivalry
3.4. Market dynamics
3.4.1. Drivers
3.4.1.1. Rise in prevalence of obesity
3.4.1.2. Increase in prevalence of type 2 diabetes
3.4.1.3. Increase in awareness among people regarding adverse effects of obesity
3.4.2. Restraints
3.4.2.1. Side effects of obesity intervention procedures
3.4.3. Opportunities
3.4.3.1. Surge in number of market players who manufacture obesity intervention devices.
3.5. COVID-19 Impact Analysis on the market
CHAPTER 4: OBESITY INTERVENTION DEVICES MARKET, BY DEVICE
4.1. Overview
4.1.1. Market size and forecast
4.2. Gastric Bands
4.2.1. Key market trends, growth factors and opportunities
4.2.2. Market size and forecast, by region
4.2.3. Market share analysis by country
4.3. Gastric Balloon
4.3.1. Key market trends, growth factors and opportunities
4.3.2. Market size and forecast, by region
4.3.3. Market share analysis by country
4.4. Gastric stimulation system
4.4.1. Key market trends, growth factors and opportunities
4.4.2. Market size and forecast, by region
4.4.3. Market share analysis by country
CHAPTER 5: OBESITY INTERVENTION DEVICES MARKET, BY END USER
5.1. Overview
5.1.1. Market size and forecast
5.2. Hospitals
5.2.1. Key market trends, growth factors and opportunities
5.2.2. Market size and forecast, by region
5.2.3. Market share analysis by country
5.3. Clinics
5.3.1. Key market trends, growth factors and opportunities
5.3.2. Market size and forecast, by region
5.3.3. Market share analysis by country
CHAPTER 6: OBESITY INTERVENTION DEVICES MARKET, BY REGION
6.1. Overview
6.1.1. Market size and forecast By Region
6.2. North America
6.2.1. Key trends and opportunities
6.2.2. Market size and forecast, by Device
6.2.3. Market size and forecast, by End User
6.2.4. Market size and forecast, by country
6.2.4.1. U.S.
6.2.4.1.1. Key market trends, growth factors and opportunities
6.2.4.1.2. Market size and forecast, by Device
6.2.4.1.3. Market size and forecast, by End User
6.2.4.2. Canada
6.2.4.2.1. Key market trends, growth factors and opportunities
6.2.4.2.2. Market size and forecast, by Device
6.2.4.2.3. Market size and forecast, by End User
6.2.4.3. Mexico
6.2.4.3.1. Key market trends, growth factors and opportunities
6.2.4.3.2. Market size and forecast, by Device
6.2.4.3.3. Market size and forecast, by End User
6.3. Europe
6.3.1. Key trends and opportunities
6.3.2. Market size and forecast, by Device
6.3.3. Market size and forecast, by End User
6.3.4. Market size and forecast, by country
6.3.4.1. Germany
6.3.4.1.1. Key market trends, growth factors and opportunities
6.3.4.1.2. Market size and forecast, by Device
6.3.4.1.3. Market size and forecast, by End User
6.3.4.2. France
6.3.4.2.1. Key market trends, growth factors and opportunities
6.3.4.2.2. Market size and forecast, by Device
6.3.4.2.3. Market size and forecast, by End User
6.3.4.3. UK
6.3.4.3.1. Key market trends, growth factors and opportunities
6.3.4.3.2. Market size and forecast, by Device
6.3.4.3.3. Market size and forecast, by End User
6.3.4.4. Italy
6.3.4.4.1. Key market trends, growth factors and opportunities
6.3.4.4.2. Market size and forecast, by Device
6.3.4.4.3. Market size and forecast, by End User
6.3.4.5. Spain
6.3.4.5.1. Key market trends, growth factors and opportunities
6.3.4.5.2. Market size and forecast, by Device
6.3.4.5.3. Market size and forecast, by End User
6.3.4.6. Rest of Europe
6.3.4.6.1. Key market trends, growth factors and opportunities
6.3.4.6.2. Market size and forecast, by Device
6.3.4.6.3. Market size and forecast, by End User
6.4. Asia-Pacific
6.4.1. Key trends and opportunities
6.4.2. Market size and forecast, by Device
6.4.3. Market size and forecast, by End User
6.4.4. Market size and forecast, by country
6.4.4.1. Japan
6.4.4.1.1. Key market trends, growth factors and opportunities
6.4.4.1.2. Market size and forecast, by Device
6.4.4.1.3. Market size and forecast, by End User
6.4.4.2. China
6.4.4.2.1. Key market trends, growth factors and opportunities
6.4.4.2.2. Market size and forecast, by Device
6.4.4.2.3. Market size and forecast, by End User
6.4.4.3. India
6.4.4.3.1. Key market trends, growth factors and opportunities
6.4.4.3.2. Market size and forecast, by Device
6.4.4.3.3. Market size and forecast, by End User
6.4.4.4. Australia
6.4.4.4.1. Key market trends, growth factors and opportunities
6.4.4.4.2. Market size and forecast, by Device
6.4.4.4.3. Market size and forecast, by End User
6.4.4.5. South Korea
6.4.4.5.1. Key market trends, growth factors and opportunities
6.4.4.5.2. Market size and forecast, by Device
6.4.4.5.3. Market size and forecast, by End User
6.4.4.6. Rest of Asia-Pacific
6.4.4.6.1. Key market trends, growth factors and opportunities
6.4.4.6.2. Market size and forecast, by Device
6.4.4.6.3. Market size and forecast, by End User
6.5. LAMEA
6.5.1. Key trends and opportunities
6.5.2. Market size and forecast, by Device
6.5.3. Market size and forecast, by End User
6.5.4. Market size and forecast, by country
6.5.4.1. Brazil
6.5.4.1.1. Key market trends, growth factors and opportunities
6.5.4.1.2. Market size and forecast, by Device
6.5.4.1.3. Market size and forecast, by End User
6.5.4.2. Saudi Arabia
6.5.4.2.1. Key market trends, growth factors and opportunities
6.5.4.2.2. Market size and forecast, by Device
6.5.4.2.3. Market size and forecast, by End User
6.5.4.3. South Africa
6.5.4.3.1. Key market trends, growth factors and opportunities
6.5.4.3.2. Market size and forecast, by Device
6.5.4.3.3. Market size and forecast, by End User
6.5.4.4. Rest of LAMEA
6.5.4.4.1. Key market trends, growth factors and opportunities
6.5.4.4.2. Market size and forecast, by Device
6.5.4.4.3. Market size and forecast, by End User
CHAPTER 7: COMPETITIVE LANDSCAPE
7.1. Introduction
7.2. Top winning strategies
7.3. Product Mapping of Top 10 Player
7.4. Competitive Dashboard
7.5. Competitive Heatmap
7.6. Top player positioning, 2021
CHAPTER 8: COMPANY PROFILES
8.1. Apollo Endosurgery
8.1.1. Company overview
8.1.2. Key Executives
8.1.3. Company snapshot
8.1.4. Operating business segments
8.1.5. Product portfolio
8.1.6. Business performance
8.1.7. Key strategic moves and developments
8.2. ReShape Lifesciences Inc
8.2.1. Company overview
8.2.2. Key Executives
8.2.3. Company snapshot
8.2.4. Operating business segments
8.2.5. Product portfolio
8.2.6. Business performance
8.3. GI Dynamics
8.3.1. Company overview
8.3.2. Key Executives
8.3.3. Company snapshot
8.3.4. Operating business segments
8.3.5. Product portfolio
8.4. Abbvie Inc (Allergan)
8.4.1. Company overview
8.4.2. Key Executives
8.4.3. Company snapshot
8.4.4. Operating business segments
8.4.5. Product portfolio
8.4.6. Business performance
8.5. A.M.I. GmbH
8.5.1. Company overview
8.5.2. Key Executives
8.5.3. Company snapshot
8.5.4. Operating business segments
8.5.5. Product portfolio
8.6. Allurion Technologies, Inc.
8.6.1. Company overview
8.6.2. Key Executives
8.6.3. Company snapshot
8.6.4. Operating business segments
8.6.5. Product portfolio
8.7. Endalis Laboratoire
8.7.1. Company overview
8.7.2. Key Executives
8.7.3. Company snapshot
8.7.4. Operating business segments
8.7.5. Product portfolio
8.8. Johnson & Johnson
8.8.1. Company overview
8.8.2. Key Executives
8.8.3. Company snapshot
8.8.4. Operating business segments
8.8.5. Product portfolio
8.8.6. Business performance
8.9. Spatz FGIA Inc
8.9.1. Company overview
8.9.2. Key Executives
8.9.3. Company snapshot
8.9.4. Operating business segments
8.9.5. Product portfolio
8.9.6. Key strategic moves and developments
8.10. Cousin Surgery
8.10.1. Company overview
8.10.2. Key Executives
8.10.3. Company snapshot
8.10.4. Operating business segments
8.10.5. Product portfolio
TABLE 01. GLOBAL OBESITY INTERVENTION DEVICES MARKET, BY DEVICE, 2021-2031 ($MILLION)
TABLE 02. OBESITY INTERVENTION DEVICES MARKET FOR GASTRIC BANDS, BY REGION, 2021-2031 ($MILLION)
TABLE 03. OBESITY INTERVENTION DEVICES MARKET FOR GASTRIC BALLOON, BY REGION, 2021-2031 ($MILLION)
TABLE 04. OBESITY INTERVENTION DEVICES MARKET FOR GASTRIC STIMULATION SYSTEM, BY REGION, 2021-2031 ($MILLION)
TABLE 05. GLOBAL OBESITY INTERVENTION DEVICES MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 06. OBESITY INTERVENTION DEVICES MARKET FOR HOSPITALS, BY REGION, 2021-2031 ($MILLION)
TABLE 07. OBESITY INTERVENTION DEVICES MARKET FOR CLINICS, BY REGION, 2021-2031 ($MILLION)
TABLE 08. OBESITY INTERVENTION DEVICES MARKET, BY REGION, 2021-2031 ($MILLION)
TABLE 09. NORTH AMERICA OBESITY INTERVENTION DEVICES MARKET, BY DEVICE, 2021-2031 ($MILLION)
TABLE 10. NORTH AMERICA OBESITY INTERVENTION DEVICES MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 11. NORTH AMERICA OBESITY INTERVENTION DEVICES MARKET, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 12. U.S. OBESITY INTERVENTION DEVICES MARKET, BY DEVICE, 2021-2031 ($MILLION)
TABLE 13. U.S. OBESITY INTERVENTION DEVICES MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 14. CANADA OBESITY INTERVENTION DEVICES MARKET, BY DEVICE, 2021-2031 ($MILLION)
TABLE 15. CANADA OBESITY INTERVENTION DEVICES MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 16. MEXICO OBESITY INTERVENTION DEVICES MARKET, BY DEVICE, 2021-2031 ($MILLION)
TABLE 17. MEXICO OBESITY INTERVENTION DEVICES MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 18. EUROPE OBESITY INTERVENTION DEVICES MARKET, BY DEVICE, 2021-2031 ($MILLION)
TABLE 19. EUROPE OBESITY INTERVENTION DEVICES MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 20. EUROPE OBESITY INTERVENTION DEVICES MARKET, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 21. GERMANY OBESITY INTERVENTION DEVICES MARKET, BY DEVICE, 2021-2031 ($MILLION)
TABLE 22. GERMANY OBESITY INTERVENTION DEVICES MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 23. FRANCE OBESITY INTERVENTION DEVICES MARKET, BY DEVICE, 2021-2031 ($MILLION)
TABLE 24. FRANCE OBESITY INTERVENTION DEVICES MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 25. UK OBESITY INTERVENTION DEVICES MARKET, BY DEVICE, 2021-2031 ($MILLION)
TABLE 26. UK OBESITY INTERVENTION DEVICES MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 27. ITALY OBESITY INTERVENTION DEVICES MARKET, BY DEVICE, 2021-2031 ($MILLION)
TABLE 28. ITALY OBESITY INTERVENTION DEVICES MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 29. SPAIN OBESITY INTERVENTION DEVICES MARKET, BY DEVICE, 2021-2031 ($MILLION)
TABLE 30. SPAIN OBESITY INTERVENTION DEVICES MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 31. REST OF EUROPE OBESITY INTERVENTION DEVICES MARKET, BY DEVICE, 2021-2031 ($MILLION)
TABLE 32. REST OF EUROPE OBESITY INTERVENTION DEVICES MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 33. ASIA-PACIFIC OBESITY INTERVENTION DEVICES MARKET, BY DEVICE, 2021-2031 ($MILLION)
TABLE 34. ASIA-PACIFIC OBESITY INTERVENTION DEVICES MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 35. ASIA-PACIFIC OBESITY INTERVENTION DEVICES MARKET, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 36. JAPAN OBESITY INTERVENTION DEVICES MARKET, BY DEVICE, 2021-2031 ($MILLION)
TABLE 37. JAPAN OBESITY INTERVENTION DEVICES MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 38. CHINA OBESITY INTERVENTION DEVICES MARKET, BY DEVICE, 2021-2031 ($MILLION)
TABLE 39. CHINA OBESITY INTERVENTION DEVICES MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 40. INDIA OBESITY INTERVENTION DEVICES MARKET, BY DEVICE, 2021-2031 ($MILLION)
TABLE 41. INDIA OBESITY INTERVENTION DEVICES MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 42. AUSTRALIA OBESITY INTERVENTION DEVICES MARKET, BY DEVICE, 2021-2031 ($MILLION)
TABLE 43. AUSTRALIA OBESITY INTERVENTION DEVICES MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 44. SOUTH KOREA OBESITY INTERVENTION DEVICES MARKET, BY DEVICE, 2021-2031 ($MILLION)
TABLE 45. SOUTH KOREA OBESITY INTERVENTION DEVICES MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 46. REST OF ASIA-PACIFIC OBESITY INTERVENTION DEVICES MARKET, BY DEVICE, 2021-2031 ($MILLION)
TABLE 47. REST OF ASIA-PACIFIC OBESITY INTERVENTION DEVICES MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 48. LAMEA OBESITY INTERVENTION DEVICES MARKET, BY DEVICE, 2021-2031 ($MILLION)
TABLE 49. LAMEA OBESITY INTERVENTION DEVICES MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 50. LAMEA OBESITY INTERVENTION DEVICES MARKET, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 51. BRAZIL OBESITY INTERVENTION DEVICES MARKET, BY DEVICE, 2021-2031 ($MILLION)
TABLE 52. BRAZIL OBESITY INTERVENTION DEVICES MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 53. SAUDI ARABIA OBESITY INTERVENTION DEVICES MARKET, BY DEVICE, 2021-2031 ($MILLION)
TABLE 54. SAUDI ARABIA OBESITY INTERVENTION DEVICES MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 55. SOUTH AFRICA OBESITY INTERVENTION DEVICES MARKET, BY DEVICE, 2021-2031 ($MILLION)
TABLE 56. SOUTH AFRICA OBESITY INTERVENTION DEVICES MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 57. REST OF LAMEA OBESITY INTERVENTION DEVICES MARKET, BY DEVICE, 2021-2031 ($MILLION)
TABLE 58. REST OF LAMEA OBESITY INTERVENTION DEVICES MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 59. APOLLO ENDOSURGERY: KEY EXECUTIVES
TABLE 60. APOLLO ENDOSURGERY: COMPANY SNAPSHOT
TABLE 61. APOLLO ENDOSURGERY: PRODUCT SEGMENTS
TABLE 62. APOLLO ENDOSURGERY: PRODUCT PORTFOLIO
TABLE 63. APOLLO ENDOSURGERY: KEY STRATERGIES
TABLE 64. RESHAPE LIFESCIENCES INC: KEY EXECUTIVES
TABLE 65. RESHAPE LIFESCIENCES INC: COMPANY SNAPSHOT
TABLE 66. RESHAPE LIFESCIENCES INC: PRODUCT SEGMENTS
TABLE 67. RESHAPE LIFESCIENCES INC: PRODUCT PORTFOLIO
TABLE 68. GI DYNAMICS: KEY EXECUTIVES
TABLE 69. GI DYNAMICS: COMPANY SNAPSHOT
TABLE 70. GI DYNAMICS: PRODUCT SEGMENTS
TABLE 71. GI DYNAMICS: PRODUCT PORTFOLIO
TABLE 72. ABBVIE INC (ALLERGAN): KEY EXECUTIVES
TABLE 73. ABBVIE INC (ALLERGAN): COMPANY SNAPSHOT
TABLE 74. ABBVIE INC (ALLERGAN): PRODUCT SEGMENTS
TABLE 75. ABBVIE INC (ALLERGAN): PRODUCT PORTFOLIO
TABLE 76. A.M.I. GMBH: KEY EXECUTIVES
TABLE 77. A.M.I. GMBH: COMPANY SNAPSHOT
TABLE 78. A.M.I. GMBH: PRODUCT SEGMENTS
TABLE 79. A.M.I. GMBH: PRODUCT PORTFOLIO
TABLE 80. ALLURION TECHNOLOGIES, INC.: KEY EXECUTIVES
TABLE 81. ALLURION TECHNOLOGIES, INC.: COMPANY SNAPSHOT
TABLE 82. ALLURION TECHNOLOGIES, INC.: PRODUCT SEGMENTS
TABLE 83. ALLURION TECHNOLOGIES, INC.: PRODUCT PORTFOLIO
TABLE 84. ENDALIS LABORATOIRE: KEY EXECUTIVES
TABLE 85. ENDALIS LABORATOIRE: COMPANY SNAPSHOT
TABLE 86. ENDALIS LABORATOIRE: PRODUCT SEGMENTS
TABLE 87. ENDALIS LABORATOIRE: PRODUCT PORTFOLIO
TABLE 88. JOHNSON & JOHNSON: KEY EXECUTIVES
TABLE 89. JOHNSON & JOHNSON: COMPANY SNAPSHOT
TABLE 90. JOHNSON & JOHNSON: PRODUCT SEGMENTS
TABLE 91. JOHNSON & JOHNSON: PRODUCT PORTFOLIO
TABLE 92. SPATZ FGIA INC: KEY EXECUTIVES
TABLE 93. SPATZ FGIA INC: COMPANY SNAPSHOT
TABLE 94. SPATZ FGIA INC: PRODUCT SEGMENTS
TABLE 95. SPATZ FGIA INC: PRODUCT PORTFOLIO
TABLE 96. SPATZ FGIA INC: KEY STRATERGIES
TABLE 97. COUSIN SURGERY: KEY EXECUTIVES
TABLE 98. COUSIN SURGERY: COMPANY SNAPSHOT
TABLE 99. COUSIN SURGERY: PRODUCT SEGMENTS
TABLE 100. COUSIN SURGERY: PRODUCT PORTFOLIO
*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
